DAC

Dividend Assets Capital Portfolio holdings

AUM $551M
1-Year Return 15.17%
This Quarter Return
+10.14%
1 Year Return
+15.17%
3 Year Return
+61.97%
5 Year Return
+110.56%
10 Year Return
+173.21%
AUM
$471M
AUM Growth
+$35.1M
Cap. Flow
-$276K
Cap. Flow %
-0.06%
Top 10 Hldgs %
33.6%
Holding
587
New
17
Increased
110
Reduced
129
Closed
42

Sector Composition

1 Energy 19%
2 Technology 13.79%
3 Financials 10.39%
4 Healthcare 9.98%
5 Industrials 9.66%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
NOC icon
176
Northrop Grumman
NOC
$83.2B
$119K 0.03%
219
CLX icon
177
Clorox
CLX
$15.5B
$117K 0.02%
832
USB icon
178
US Bancorp
USB
$75.9B
$117K 0.02%
2,691
GLD icon
179
SPDR Gold Trust
GLD
$112B
$113K 0.02%
669
SCHW icon
180
Charles Schwab
SCHW
$167B
$112K 0.02%
1,342
GE icon
181
GE Aerospace
GE
$296B
$109K 0.02%
2,088
-511
-20% -$26.7K
VFC icon
182
VF Corp
VFC
$5.86B
$108K 0.02%
3,895
-4,611
-54% -$128K
ED icon
183
Consolidated Edison
ED
$35.4B
$107K 0.02%
1,120
+560
+100% +$53.5K
BEP icon
184
Brookfield Renewable
BEP
$7.06B
$106K 0.02%
4,200
-27,207
-87% -$687K
MKC icon
185
McCormick & Company Non-Voting
MKC
$19B
$105K 0.02%
1,270
MS icon
186
Morgan Stanley
MS
$236B
$105K 0.02%
1,233
-34
-3% -$2.9K
VTWO icon
187
Vanguard Russell 2000 ETF
VTWO
$12.8B
$104K 0.02%
1,478
+164
+12% +$11.5K
XEL icon
188
Xcel Energy
XEL
$43B
$102K 0.02%
1,460
VWO icon
189
Vanguard FTSE Emerging Markets ETF
VWO
$97.2B
$101K 0.02%
2,597
TSLA icon
190
Tesla
TSLA
$1.13T
$99K 0.02%
804
-60
-7% -$7.39K
CME icon
191
CME Group
CME
$94.4B
$98K 0.02%
580
UGI icon
192
UGI
UGI
$7.43B
$95K 0.02%
2,551
KLAC icon
193
KLA
KLAC
$119B
$94K 0.02%
250
FCX icon
194
Freeport-McMoran
FCX
$66.5B
$93K 0.02%
2,450
+100
+4% +$3.8K
CCI icon
195
Crown Castle
CCI
$41.9B
$88K 0.02%
650
NVDA icon
196
NVIDIA
NVDA
$4.07T
$88K 0.02%
6,000
LNT icon
197
Alliant Energy
LNT
$16.6B
$84K 0.02%
1,520
+760
+100% +$42K
IJJ icon
198
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.15B
$83K 0.02%
826
CAG icon
199
Conagra Brands
CAG
$9.23B
$80K 0.02%
2,080
+1,040
+100% +$40K
NVS icon
200
Novartis
NVS
$251B
$78K 0.02%
857